Recent Updates
Recently added Catalysts
INO Positive Sentiment Score: 60/100

INOVIO to Report Third Quarter 2023 Financial Results on November 9, 2023

Thursday, October 26, 2023 1 min read
Key Takeaway: INOVIO (NASDAQ: INO) has announced that it will release its financial results for the third quarter of 2023 on November 9, 2023, after market close. Along with the financial report, the company will host a live conference call and webcast at 4:30 p.m. ET to discuss its results and provide an update on its business. INOVIO specializes in developing DNA medicines aimed at treating HPV-related diseases, cancer, and infectious diseases.

Market Sentiment Analysis

POSITIVE FACTORS

  • INOVIO is set to share its third quarter financial results, indicating active business operations.
  • The company is focused on innovative DNA medicines, which could lead to significant health advancements.
  • A live Q&A session will allow for direct engagement with analysts, fostering transparency and investor confidence.

Full Press Release Details

PLYMOUTH MEETING, Pa., Oct. 26, 2023 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases, today announced that third quarter 2023 financial results will be released after the market close on November 9, 2023. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss financial results and provide a general business update.
A live and archived version of the audio presentation will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts.
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.
Media: Jennie Willson (267) 429-8567 [email protected]
Investors: Thomas Hong (267) 440-4298 [email protected]
SOURCE INOVIO Pharmaceuticals, Inc.

21 %

more press release views with

Frequently Asked Questions

When will INOVIO release its Q3 2023 financial results?

INOVIO will release its Q3 2023 financial results on November 9, 2023.

What will happen after INOVIO's financial results are released?

INOVIO will host a conference call and webcast at 4:30 p.m. ET for an update.

Where can I find the live presentation of INOVIO's conference call?

The live presentation will be available at http://ir.inovio.com/events-and-presentations/default.aspx.

What focus does INOVIO have in biotechnology?

INOVIO specializes in developing DNA medicines to treat HPV-related diseases and cancers.

Is there a Q&A session during the INOVIO conference call?

Yes, there will be a live Q&A session with analysts during the call.

Tags: INO Viatris Investor Conferences Healthcare INOVIO NASDAQ INO financial results biotechnology DNA medicines
Last updated: Oct 26, 2023